SEC Form 4 · accession 0001140361-17-046690
CYTRX CORP · CYTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel K Caldwell
Director
Period of report
Dec 15, 2017
Accepted (ET)
Dec 19, 2017 · 2:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000799698
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | $1.75 | Dec 15, 2017 | A | 30,000 | A | Dec 15, 2017 | Dec 14, 2027 | CytRx Common Stock | 30,000 | 30,000 | D |